These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 30530050)

  • 1. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.
    Novellasdemunt L; Antas P; Li VS
    Am J Physiol Cell Physiol; 2015 Oct; 309(8):C511-21. PubMed ID: 26289750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
    Phull MS; Jadav SS; Gundla R; Mainkar PS
    Eur J Med Chem; 2021 Feb; 212():113149. PubMed ID: 33445154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
    Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
    J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
    Masuda M; Sawa M; Yamada T
    Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies.
    Amado NG; Predes D; Moreno MM; Carvalho IO; Mendes FA; Abreu JG
    Int J Mol Sci; 2014 Jul; 15(7):12094-106. PubMed ID: 25007066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
    Disoma C; Zhou Y; Li S; Peng J; Xia Z
    Biochimie; 2022 Apr; 195():39-53. PubMed ID: 35066101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
    Chen Y; Chen M; Deng K
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.